Host and Fungal Regulation of Type 17 Immunity to Oral Candidiasis
Host and Fungal Regulation of Type 17 Immunity to Oral Candidiasis
批准号:
10673918
负责人:
Sarah L Gaffen
金额:
$57.74万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2027-07-31
关键词:
AccelerationAcquired Immunodeficiency SyndromeAdaptive Immune SystemAdrenal Cortex HormonesAntifungal AgentsAreaAutomobile DrivingCCAAT-Enhancer-Binding ProteinsCandida albicansCandidiasisCell CommunicationCell CompartmentationCell Differentiation processCell ProliferationCell membraneCellsClientCytokine ReceptorsCytokine SignalingDataData SetDiseaseElderlyEpidermal Growth Factor ReceptorEpithelial CellsEpitheliumEventFamilyFamily memberFundingGoalsGrantHomeostasisHost DefenseHumanHyphaeIL17 geneImmuneImmune responseImmune systemImmunityImmunologyImmunosuppressive AgentsIndividualInfantInfectionInhalationInnate Immune SystemInterleukin-1LaboratoriesLeadLocationLymphocyteMAP Kinase GeneMediatingMicrobeMolecularMorphologyMouth DiseasesMucosal ImmunityMucous MembraneMusMycosesNF-kappa BNeutrophil InfiltrationOralOral candidiasisOral cavityOral mucous membrane structurePathway interactionsPeptidesPermeabilityPharmaceutical PreparationsProductionPropertyRNA StabilityRNA-Binding ProteinsRegulationReportingResearchSTAT3 geneSignal InductionSignal PathwaySignal TransductionSignal Transduction InductionSiteSourceStromal CellsSystemT cell responseT-LymphocyteTIS11 proteinTissuesToxinTranscriptTranslationsTransplant RecipientsUp-RegulationVirulenceVirulence FactorsWorkantimicrobial peptideasthmatic patientcell typechemokinechemotherapycytokinedraining lymph nodeepithelial repairfungusimmune functioninterestinterleukin-22interleukin-23model organismmucosal vaccineoral cavity epitheliumoral immunityoral infectionoral pathogenoral tissueoropharyngeal thrushp38 Mitogen Activated Protein Kinasepathogenpathogenic fungusposttranscriptionalresponsesingle-cell RNA sequencingstemtissue regenerationtissue repairtraittranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Oropharyngeal candidiasis (OPC) is an opportunistic fungal infection associated with
immune deficiency, particularly in the T cell compartment. C. albicans is a commensal
fungus that is the dominant causative species of OPC, and its key virulence trait is the
ability to form invasive hyphae. This morphologic transition in the fungus triggers
‘danger’ responses in oral epithelial cells (OECs), which are the first cell types to
encounter this microbe. In 2009, we showed that an effective immune response to
mucosal candidiasis in mice requires signaling by the cytokine IL-17 (IL-17A). The
importance of IL-17 was confirmed in humans with IL-17R-deficiencies. Using mice as a
model organism, we showed that in naïve settings (i.e., innate responses), IL-17 is made
by two innate lymphocyte cell subsets: gd-T and ‘natural’ Th17 cells (nTh17). In recall
(i.e., adaptive) responses, IL-17 is additionally made by conventional CD4+Th17 cells,
which augment the innate response to accelerate fungal clearance. Collectively, IL-17+
cells comprise “Type 17” immunity. Regardless of source, IL-17 signals through a
heterodimer of IL-17RA and IL-17RC, which is highly expressed on cells of the stromal
and epithelial compartments. The initiating event in OPC is exposure of OECs to C.
albicans. However, it remains unclear how early epithelial recognition events lead to
activation of Type 17 responses, and why these responses occur only in response to
hyphae. In a landmark discovery the co-I (Dr. Naglik) showed that the danger response
in OECs is activated by a virulence factor, Candidalysin, the first pore-forming peptide
toxin identified in any human fungal pathogen. Candidalysin is secreted only by hyphae
and permeabilizes OEC membranes. Candidalysin triggers a MAPK-dependent
pathway, leading to upregulation of cytokines, chemokines and antimicrobial peptides
that are essential for immunity to OPC. Our overarching goal in this continuation is to
define in depth the mechanisms by which host-and pathogen-derived factors
coordinate effective Type 17 immunity against C. albicans.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1111/cmi.13378
发表时间:
2021-10
期刊:
Cellular microbiology
影响因子:
3.4
作者:
[Mogavero S, Sauer FM, Brunke S, Allert S, Schulz D, Wisgott S, Jablonowski N, Elshafee O, Krüger T, Kniemeyer O, Brakhage AA, Naglik JR, Dolk E, Hube B]
通讯作者:
Hube B
DOI:
10.3390/jof3040056
发表时间:
2017-10-07
期刊:
Journal of fungi (Basel, Switzerland)
影响因子:
--
作者:
[Witherden EA, Shoaie S, Hall RA, Moyes DL]
通讯作者:
Moyes DL
DOI:
10.1128/mbio.00531-21
发表时间:
2021-06-29
期刊:
mBio
影响因子:
6.4
作者:
[Austermeier S, Pekmezović M, Porschitz P, Lee S, Kichik N, Moyes DL, Ho J, Kotowicz NK, Naglik JR, Hube B, Gresnigt MS]
通讯作者:
Gresnigt MS
DOI:
10.1080/1040841x.2020.1843400
发表时间:
2021-03
期刊:
Critical reviews in microbiology
影响因子:
6.5
作者:
[Ponde NO, Lortal L, Ramage G, Naglik JR, Richardson JP]
通讯作者:
Richardson JP
DOI:
10.3389/fmicb.2021.633047
发表时间:
2021
期刊:
Frontiers in microbiology
影响因子:
5.2
作者:
[Griffiths JS, Camilli G, Kotowicz NK, Ho J, Richardson JP, Naglik JR]
通讯作者:
Naglik JR
共 9 条
Host and Fungal Regulation of Type 17 Immunity to Oral Candidiasis
-
批准号:10551422
-
项目类别:
-
资助金额:$59.74万
-
财政年份:2022
-
负责人:Sarah L Gaffen
-
依托单位:
Molecular Mechanisms of IL-17-dependent autoimmune signaling
-
批准号:10524055
-
项目类别:
-
资助金额:$50.69万
-
财政年份:2019
-
负责人:Sarah L Gaffen
-
依托单位:
Molecular Mechanisms of IL-17-dependent autoimmune signaling
-
批准号:10304158
-
项目类别:
-
资助金额:$50.69万
-
财政年份:2019
-
负责人:Sarah L Gaffen
-
依托单位:
Molecular Mechanisms of IL-17-dependent autoimmune signaling
-
批准号:10065494
-
项目类别:
-
资助金额:$51.89万
-
财政年份:2019
-
负责人:Sarah L Gaffen
-
依托单位:
Molecular Mechanisms of IL-17-dependent autoimmune signaling
-
批准号:9913154
-
项目类别:
-
资助金额:$51.42万
-
财政年份:2019
-
负责人:Sarah L Gaffen
-
依托单位:
IL-23/STAT3-Driven Oral Immune Responses to Candida albicans
-
批准号:8977508
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:Sarah L Gaffen
-
依托单位:
Negative Control of IL-17R Signaling: Implications for Fungal Immunity
-
批准号:8976213
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2014
-
负责人:Sarah L Gaffen
-
依托单位:
Negative Control of IL-17R Signaling: Implications for Fungal Immunity
-
批准号:8692225
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2014
-
负责人:Sarah L Gaffen
-
依托单位:
IL-23/STAT3-Driven Oral Immune Responses to Candida albicans
-
批准号:9193080
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:Sarah L Gaffen
-
依托单位:
IL-23/STAT3-Driven Oral Immune Responses to Candida albicans
-
批准号:8611195
-
项目类别:
-
资助金额:$38.31万
-
财政年份:2014
-
负责人:Sarah L Gaffen
-
依托单位:
2013 Joint Meeting of the International Cytokine Society & International Society
-
批准号:8596970
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2013
-
负责人:Sarah L Gaffen
-
依托单位:
IL-17 Receptor Signaling in the Oral Mucosa
-
批准号:8270744
-
项目类别:
-
资助金额:$36.82万
-
财政年份:2012
-
负责人:Sarah L Gaffen
-
依托单位:
Host and Fungal Regulation of Type 17 Immunity to Oral Candidiasis
-
批准号:9397690
-
项目类别:
-
资助金额:$54.66万
-
财政年份:2012
-
负责人:Sarah L Gaffen
-
依托单位:
IL-17 Receptor Signaling in the Oral Mucosa
-
批准号:8636009
-
项目类别:
-
资助金额:$44.39万
-
财政年份:2012
-
负责人:Sarah L Gaffen
-
依托单位:
IL-17 Receptor Signaling in the Oral Mucosa
-
批准号:8442240
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2012
-
负责人:Sarah L Gaffen
-
依托单位:
IL-17 Receptor Signaling in the Oral Mucosa
-
批准号:8817272
-
项目类别:
-
资助金额:$42.18万
-
财政年份:2012
-
负责人:Sarah L Gaffen
-
依托单位:
IL-17 Receptor Signaling in the Oral Mucosa
-
批准号:8705624
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2012
-
负责人:Sarah L Gaffen
-
依托单位:
Host and Fungal Regulation of Type 17 Immunity to Oral Candidiasis
-
批准号:10213694
-
项目类别:
-
资助金额:$52.81万
-
财政年份:2012
-
负责人:Sarah L Gaffen
-
依托单位:
Th17-mediated immunity to fungal infections
-
批准号:8100877
-
项目类别:
-
资助金额:$65.44万
-
财政年份:2010
-
负责人:Sarah L Gaffen
-
依托单位:
T helper cell responses in Tanerella forsythia-induced alveolar bone destruction
-
批准号:8104124
-
项目类别:
-
资助金额:$37.48万
-
财政年份:2008
-
负责人:Sarah L Gaffen
-
依托单位:
海外基金